I agree & am a reasonably long term holder who has seen nothing but dilution & erosion of capital. Even this qtrs improvement with Experience wasn't down to good company management but wider supply chain issues with saline supply. Blastx should be selling itself. Maybe, just maybe they will get traction in a few years but don't expect miracles with this mgmt team. I expect another CR or 2 but i won't be participating. unfortunately not all investments are winners & this is one of my losers. Thankfully i have a decent position in another Australian biotech that is kicking goals & improving lives, particularly for paraplegics. Not trying to cross promote so i won't mention the name. Sabine you know the company.. now all of the above is my personal opinion & I am just a small retailer so please dyor I do hope they can turn this around but it won't be quickly.
NXS Price at posting:
13.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)